FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive Stage Small Cell Lung Cancer By Ogkologos - January 22, 2026 281 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the DeLLphi-304 study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Atezolizumab Approved for Initial Treatment of Metastatic Lung Cancer January 7, 2019 Whole- and Partial-Breast Radiation Effective at Preventing Breast Cancer from Returning December 19, 2018 Plasma Lipid Biomarker PCPro Associated with Shorter OS and Earlier Clinical... May 27, 2025 Apple Season is Here! October 1, 2021 Load more HOT NEWS ¿Qué deben saber las personas con cáncer sobre el consumo de... A Large Case-Control Study of Hodgkin Lymphoma Survivors Suggests a Dose-Response... John Cena Set The Record For Most Make-A-Wish Visits And He... FDA Approves Zolbetuximab-clzb with Chemotherapy for Gastric or Gastro-Oesophageal Junction Adenocarcinoma
